Citation Impact
Citing Papers
Rapid tolerization of virus-activated tumor-specific CD8 + T cells in prostate tumors of TRAMP mice
2008
Programmed cell death 1 inhibits inflammatory helper T-cell development through controlling the innate immune response
2013 StandoutNobel
Global analysis of protein folding using massively parallel design, synthesis, and testing
2017 StandoutScienceNobel
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
Spontaneous tumor rejection by cbl-b –deficient CD8+ T cells
2007
Computational Thermostabilization of an Enzyme
2005 StandoutScienceNobel
PD-1 + regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
2019 StandoutNobel
Aire-Dependent Thymic Development of Tumor-Associated Regulatory T Cells
2013 StandoutScienceNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Cancer Immunosurveillance and Immunoediting: The Roles of Immunity in Suppressing Tumor Development and Shaping Tumor Immunogenicity
2006
Modeling electrostatic effects in proteins
2006 StandoutNobel
The PD-1–PD-L pathway in immunological tolerance
2006 StandoutNobel
Conservation of rapid two-state folding in mesophilic, thermophilic and hyperthermophilic cold shock proteins
1998
Cancer despite immunosurveillance: immunoselection and immunosubversion
2006
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
The Cold Shock Domain Protein LIN-28 Controls Developmental Timing in C. elegans and Is Regulated by the lin-4 RNA
1997 StandoutNobel
Specificity in cancer immunotherapy
2008
Selecting proteins with improved stability by a phage-based method
1998
The structure of the translational initiation factor IF1 from E.coli contains an oligomer-binding motif
1997
Myeloid-derived suppressor cells as regulators of the immune system
2009 Standout
Models, mechanisms and clinical evidence for cancer dormancy
2007
Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?
2007
Autophagy, Inflammation, and Immunity: A Troika Governing Cancer and Its Treatment
2016
Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells
1999 StandoutNobel
Mutational analysis of the putative nucleic acid‐binding surface of the cold‐shock domain, CspB, revealed an essential role of aromatic and basic residues in binding of single‐stranded DNA containing the Y‐box motif
1995
Expression of tumour-specific antigens underlies cancer immunoediting
2012 Nature
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
2017 StandoutNobel
Microbial Stimulation Fully Differentiates Monocytes to DC-SIGN/CD209+ Dendritic Cells for Immune T Cell Areas
2010 StandoutNobel
Immune surveillance of tumors
2007
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
2015
Gene directed enzyme/prodrug therapy of cancer: Historical appraisal and future prospectives
2001
Structural and functional properties of the evolutionarily ancient Y‐box family of nucleic acid binding proteins
1994
Universal nucleic acid-binding domain revealed by crystal structure of the B. subtilis major cold-shock protein
1993 Nature
Extremely rapid protein folding in the absence of intermediates
1995
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
A case of convergent evolution of nucleic acid binding modules
1996
T Cell Surveillance of Oncogene-Induced Prostate Cancer Is Impeded by T Cell-Derived TGF-β1 Cytokine
2011 StandoutNobel
PD-1 and PD-1 ligands: from discovery to clinical application
2007
Cancer Immunotherapy by Dendritic Cells
2008
Two exposed amino acid residues confer thermostability on a cold shock protein.
2000
Cytokine-secreting tumor cell vaccines
2000
Immune surveillance of senescent cells--biological significance in cancer- and non-cancer pathologies
2012
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
2012 StandoutNatureNobel
The Hallmarks of Aging
2013 Standout
Dendritic cells and the control of immunity
1998 StandoutNatureNobel
A surprising simplicity to protein folding
2000 StandoutNatureNobel
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
2016 StandoutNobel
Ribosome Structure and the Mechanism of Translation
2002 StandoutNobel
Do autochthonous tumors interfere with effector T cell responses?
2007
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
2011 StandoutNobel
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Nucleic Acid-Binding Properties of the Xenopus Oocyte Y Box Protein mRNP3+4
1994
A segment of cold shock protein directs the folding of a combinatorial protein
2005 StandoutNobel
Protein folding kinetics exhibit an Arrhenius temperature dependence when corrected for the temperature dependence of protein stability
1997 StandoutNobel
Novel folded protein domains generated by combinatorial shuffling of polypeptide segments
2000 StandoutNobel
Natural Innate and Adaptive Immunity to Cancer
2011 Standout
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Flt3 permits survival during infection by rendering dendritic cells competent to activate NK cells
2010 StandoutNobel
Crystal structure of CspA, the major cold shock protein of Escherichia coli.
1994
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Crystal Structure of an Initiation Factor Bound to the 30 S Ribosomal Subunit
2001 StandoutScienceNobel
Prediction of protein-folding mechanisms from free-energy landscapes derived from native structures
1999 StandoutNobel
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors
2008 StandoutNobel
CpG Motifs as Proinflammatory Factors Render Autochthonous Tumors Permissive for Infiltration and Destruction
2004
Electrostatic basis for the unidirectionality of the primary proton transfer in cytochrome c oxidase
2008 StandoutNobel
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
Native protein sequences are close to optimal for their structures
2000 StandoutNobel
Solution NMR structure of the major cold shock protein (CspA) from Escherichia coli: identification of a binding epitope for DNA.
1994
Dendritic Cells Genetically Modified with an Adenovirus Vector Encoding the cDNA for a Model Antigen Induce Protective and Therapeutic Antitumor Immunity
1997
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
2016 Standout
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
2003 StandoutNobel
Realistic simulation of the activation of voltage-gated ion channels
2012 StandoutNobel
CD8+tumor-infiltrating lymphocytes at primary sites as a possible prognostic factor of cutaneous angiosarcoma
2013 StandoutNobel
Immunosuppressive Strategies that are Mediated by Tumor Cells
2006
PD-1 deficiency reveals various tissue-specific autoimmunity by H-2band dose-dependent requirement of H-2g7for diabetes in NOD mice
2008 StandoutNobel
Cancer Genome Landscapes
2013 StandoutScience
Immunity, inflammation, and cancer: an eternal fight between good and evil
2015
Realistic simulations of the coupling between the protomotive force and the mechanical rotation of the F 0 -ATPase
2012 StandoutNobel
Diffusion control in an elementary protein folding reaction
1997
NK cell–mediated killing of target cells triggers robust antigen-specific T cell–mediated and humoral responses
2009 StandoutNobel
Thermodynamic Properties of an Extremely Rapid Protein Folding Reaction
1996
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
2010 StandoutNobel
Interferons, immunity and cancer immunoediting
2006
Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
2017 StandoutNobel
Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas.
2001
Simulating the electrostatic guidance of the vectorial translocations in hexameric helicases and translocases
2009 StandoutNobel
On the energetics of translocon-assisted insertion of charged transmembrane helices into membranes
2010 StandoutNobel
Limited internal friction in the rate-limiting step of a two-state protein folding reaction
1998 StandoutNobel
Works of Gerald Willimsky being referenced
Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness
2008
Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse
2000
Overproduction, crystallization, and preliminary X‐ray diffraction studies of the major cold shock protein from Bacillus subtilis, CspB
1992
Tumor‐induced antibodies resemble the response to tissue damage
2005
Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance
2005 Nature
Mapping of the Bacillus subtilis cspB gene and cloning of its homologs in thermophilic, mesophilic and psychrotrophic bacilli
1993
RNA Levels of Human Retrovirus Receptors Pit1 and Pit2 Do Not Correlate with Infectibility by Three Retroviral Vector Pseudotypes
1998
Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy
2015 Nature
Interleukin-7/B7.1-encoding adenoviruses induce rejection of transplanted but not nontransplanted tumors.
2000
Characterization of cspB, a Bacillus subtilis inducible cold shock gene affecting cell viability at low temperatures
1992
Successful retroviral mediated transduction of a reporter gene in human dendritic cells: feasibility of therapy with gene-modified antigen presenting cells.
1997